CD86 and B-cell chronic lymphocytic leukemia: To confirm the activation phenotype indicated by miRNA expression profiling, we performed FACS analysis of naïve B cells, activated B cells, and CLL cells using B cell activation markers CD69, CD80, and CD86 (Figure 3 and Table S3).